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RESEARCH
Benefits of supervised group exercise programme for
women being treated for early stage breast cancer:
pragmatic randomised controlled trial
NanetteMutrie, professor of exercise and sport psychology,1AnnaMCampbell, research fellow,1 Fiona
Whyte, Macmillancancerlecturer,2AlexMcConnachie, senioranalyst,3CarolEmslie, researchscientist,4Laura
Lee, research assistant,1Nora Kearney, professor of cancer care,5AndrewWalker, health economist,3Diana
Ritchie, consultant oncologist6
ABSTRACT
Objectives To determine functional and psychological
benefits of a 12 week supervised group exercise
programme during treatment for early stage breast
cancer, with six month follow-up.
Design Pragmatic randomised controlled prospective
open trial.
Setting Three National Health Service oncology clinics in
Scotland and community exercise facilities.
Participants 203 women entered the study; 177
completed the six month follow-up.
Interventions Supervised 12 week group exercise
programme in addition to usual care, compared with
usual care.
Main outcome measures Functional assessment of
cancer therapy (FACT) questionnaire, Beck depression
inventory, positive and negative affect scale, body mass
index, seven day recall of physical activity, 12 minute
walk test, and assessment of shoulder mobility.
ResultsMixed effects models with adjustment for
baseline values, study site, treatment at baseline, and
age gave intervention effect estimates (intervention
minus control) at 12 weeks of 129 (95% confidence
interval 83 to 176) for metres walked in 12 minutes, 182
(75 to 289) for minutes of moderate intensity activity
reported in a week, 2.6 (1.6 to 3.7) for shoulder mobility,
2.5 (1.0 to 3.9) for breast cancer specific subscale of
quality of life, and 4.0 (1.8 to 6.3) for positive mood. No
significant effect was seen for general quality of life (FACT-
G), which was the primary outcome. At the six month
follow-up, most of these effects were maintained and an
intervention effect for breast cancer specific quality of life
emerged. No adverse effects were noted.
Conclusion Supervised group exercise provided
functional and psychological benefit after a 12 week
intervention and six months later. Clinicians should
encourage activity for their patients. Policymakers should
consider the inclusion of exercise opportunities in cancer
rehabilitation services.
Trial registration Current controlled trials
ISRCTN12587864.
INTRODUCTION
Breast cancer is the most commonly occurring cancer
among women in the United Kingdom. More than
40 000 new cases are reported each year, and breast
cancer accounts for 30% of the cancer burden in
women (excluding non-melanoma skin cancer). Early
detection and improved treatments for breast cancer
have resulted in increased survival rates; the current
five year relative survival rate is estimated to be
80%.1 2 Surviving cancer usually means enduring
sequential combinations of treatment modalities (sur-
gery, radiotherapy, systemic chemotherapy, and hor-
monal treatment). Treatments for cancer can result in
significant reductions in many different quality of life
outcomes.3 Current programmes in cancer rehabilita-
tion are mainly based on psychotherapy or social sup-
port. Such therapies do not usually deal with the
physical problems encountered by patients, such as
fatigue, loss of functional capacity, and weight gain.4
Exercise is an intervention that may improve a broad
range of quality of life problems after diagnosis of can-
cer.
Physical activity levels reduce significantly formany
women after a diagnosis of breast cancer and remain
low after treatment is completed.5 6 A prospective
observational study in survivors of breast cancer has
indicated a 50% risk reduction in mortality among
women who are regularly active compared with those
who remained inactive post-diagnosis.7 A recent sys-
tematic review of the effects of exercise on breast can-
cer patients and survivors concluded that exercise is an
effective intervention to improve quality of life, cardio-
respiratory fitness, physical functioning, and fatigue.8
However, a more recent Cochrane review, which
examined exercise interventions exclusively during
treatment for breast cancer, found improvements in
physical fitness and activities of daily life but no signif-
icant improvements in quality of life or fatigue.9 Little
of the existing evidence comes from the UK or a
National Health Service (NHS) setting.
We aimed to determine if participating in a super-
vised group exercise programme for women during
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treatment for early stage breast cancer had functional
and psychological benefits. We tested the hypotheses
that 12 weeks of supervised group exercise, as an
adjunct to usual care, would improve quality of life
for women during treatment for early stage breast can-
cer and that benefits would be maintained for six
months after the intervention.
METHODS
Participants
From January 2004 to January 2005, trained recruiters
approachedwomenduring appointments at outpatient
clinics for chemotherapy or radiotherapy at threeNHS
oncology centres in Scotland and presented informa-
tion about the study.10 Potential participants with stage
0-III breast cancer agreed to attend a pre-screening
meeting. Exclusion criteria were concurrent unstable
cardiac, hypertensive, or respiratory disease; cognitive
dysfunction; and regular exercise.
Protocol, assignment, and masking
This study was a two group (intervention and control)
by three time points (baseline, 12weeks, and sixmonth
follow-up) randomised controlled trial.After obtaining
written informed consent and baseline measures, we
randomly allocated women into one of two groups.
The randomisation was stratified by hospital and treat-
ment at baseline (chemotherapy, radiotherapy, or
combination) and used randomised permuted blocks
of length four and six (that is, for sequences of four or
six women in each hospital-treatment combination,
exactly half were allocated to each group). Randomisa-
tion was done by telephone to an interactive voice
response system. We entered and managed all data in
an anonymised format; we held data on patient con-
tacts and other administrative data in a separate data-
base. The study was a pragmatic, randomised,
prospective, open trial. In exercise studies, blinding
the participants to allocation is not possible. We took
steps to blind the evaluation of outcomes by having
questionnaire responses in sealed envelopes and
ensuring that outcome measures were taken by
researchers who were not involved in exercise classes.
We sent a letter to general practitioners informing
them of their patients’ participation in the study.
Outcome measures
The primary outcome measure was quality of life, as
measured by the functional assessment of cancer ther-
apy—general (FACT-G) questionnaire.11 This ques-
tionnaire comprises four core domains of quality of
life—physical (FACT-GP), functional (FACT-GF),
social (FACT-GS), and emotional (FACT-GE)—and
is considered appropriate for use with cancer patients.
Breast cancer, fatigue, and endocrine symptoms sub-
scales have been developed and, when added to the
FACT-G score, are described as FACT-B, FACT-F,
and FACT-ES.12 13 Secondary outcomes were the
Beck depression inventory, the positive and negative
affect scale, body mass index, seven day recall of phy-
sical activity (Scottish physical activity questionnaire),
performance in a 12 minute walk test, and score on a
shoulder mobility test.14-18
Intervention
Women assigned to the intervention group received
usual care from their healthcare team and, in addition,
were invited to attend a supervised group exercise pro-
gramme. The exercise programme ran for 12 weeks,
and women were encouraged to attend two classes
and do one additional exercise session at home each
week. Fourteen exercise classes led by specifically
trained exercise specialists took place in eight commu-
nity exercise facilities that were all accessible by public
transport. Classes were timetabled at various times in
the day and evening. The exercise intervention was
basedon guidelines for prescriptionof exercise for can-
cer patients and survivors.19 The classes consisted of a
warm-up of 5-10 minutes, 20 minutes of exercise (for
example walking, cycling, low level aerobics, muscle
strengthening exercises, or circuits of specifically tai-
lored exercises), and a cool-down and relaxation per-
iod. The exercise class lasted 45 minutes in total.
Women were monitored throughout the class to
ensure that they were exercising at a moderate level
(50-75% of age adjusted maximum heart rate). Each
week, for six weeks, a specific theme was covered in
group discussion after the exercise (for example, the
health benefits of exercise, enhancing self efficacy, set-
ting goals) and supported with specifically constructed
materials. These themes were guided by a model of
behaviour change andwere designed to promote inde-
pendent exercise after the intervention.20We repeated
the six week block on a rolling basis, allowing all parti-
cipants to hear the same themes. At the end of the
12 week intervention, the women were helped to con-
struct an individual exercise programmeand invited to
join a local general practice exercise referral scheme.
Further details of the intervention and the expertise of
the staff are available on our website (www.strath.ac.
uk/sca/staff/mutrie_n.html).
Women assigned to the control group received usual
care from the healthcare team and completed all out-
come measures on the same time frame as the inter-
vention group. After randomisation, this group
received a two page leaflet entitled “Exercise after can-
cer diagnosis,” which provided safe guidelines. After
the six month follow-up, these women were helped to
construct their own personalised exercise plan and
invited to join a local general practice exercise referral
scheme.
Statistical power and analysis
With 91 participants in each group, the study was
designed to have 90% power at a 5% level of signifi-
cance to detect an intervention effect of approximately
7.5 units on the change in FACT-G score after
12 weeks, assuming a standard deviation of this out-
come of 15 units. We based this change on findings
from our pilot study.21 The primary analysis, and the
main analysis applied to each secondary outcome, was
to test whether significant differences existed between
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the exercise group and control group in outcomes at
the end of the 12 week intervention period and at six
months post-intervention, adjusting for the stratifica-
tion variables (study site and treatment at baseline),
age, and baseline value of the outcome. We did the
analysis on an intention to treat basis, in the sense
that we took no account of adherence to the inter-
vention. We used all available data.
RESULTS
Participants
The recruiters approached 1144 women, and 313
agreed to attend pre-screening. We then randomised
203 women. Figure 1 shows the flow of participants
through the trial. Table 1 shows the characteristics of
the participants. The women in this study were
recruited on average six months after diagnosis, had a
mean age of just over 50, and came from a range of
occupations. No obvious imbalances existed between
study groups.
Main outcomes
Table 2 summarises the outcome variables measured
at the baseline, 12 week, and six month post-inter-
vention assessments, for the intervention and control
groups separately. Adjusted estimates of the differ-
ences between the intervention groups at 12 weeks
and sixmonths are also reported. Figure 2 shows effect
estimates and confidence intervals for all variables. All
effect estimates are reported in units of one standard
deviation of the outcome variable in question.
Mixed effects models with adjustment for baseline
values, study site, treatment at baseline, and age
showed intervention effect estimates (intervention
minus control) at 12 weeks of 129 (95% confidence
interval 83 to 176) for metres walked in 12 minutes,
182 (75 to 289) forminutes of moderate intensity activ-
ity reported in a week, 2.6 (1.6 to 3.7) for shoulder
mobility, 2.5 (1.0 to 3.9) for breast cancer specific sub-
scale quality of life, and 4.0 (1.8 to 6.3) for positive
mood. We found no significant intervention effect for
FACT-G, which was the primary outcome. We saw
non-significant trends towards increases in perceived
quality of life in relation to fatigue (+2.3 points,
P=0.091) and reduced depression (−1.7 points,
P=0.083) in favour of the intervention.
Intervention effect estimates for the six month fol-
low-up data were 105 (60 to 151) for metres walked in
12 minutes, 2.5 (1.4 to 3.6) for shoulder mobility, 1.5
(0.1 to 2.9) for breast cancer specific subscale quality of
life (when this subscale is added to the FACT-G a sig-
nificant effect (4.9, 0.2 to 9.6) for FACT-Bemerges), 1.4
(0.3 to 2.5) for the social domain (FACT-GS), and 3.9
(1.6 to 6.1) for positive mood. At the follow-up we also
saw non-significant trends towards improvements on
the primary outcome (FACT-G; +3.6 points,
P=0.053), the functional domain of the FACT-G
score (FACT-GF; +1.1 points, P=0.067), and depres-
sion (−1.8 points, P=0.064) in favour of the inter-
vention.
Figure 3 shows the use of health services in the study
up to the six month post-intervention follow-up. Ten
Approached (n=1144)
Agreed to attend pre-screening (n=313)
Randomised (n=203)
Allocated to intervention (n=101) Allocated to control (n=102)
Assessed at 12 weeks (n=82) Assessed at 12 weeks (n=92)
Assessed at 6 months (n=82) Assessed at 6 months (n=95)
Declined to attend pre-screening (n=831):
  Transport problems (n=425)
  Not interested (n=79)
  Other health problems (n=63)
  Already exercising (n=59)
  Work conflict (n=50)
  Other reasons (n=155)
Excluded (n=110):
  Did not meet inclusion criteria (n=4)
  Declined to participate (n=66)
  Other reasons (n=40)
Lost to follow-up at 12 weeks
  (n=3):
    Not contactable (n=2)
    Questionnaire not returned
      (n=1)
Lost to follow-up at 12 weeks
  (n=12):
    Never started classes, no
      contact (n=2)
    Excluded from analysis,
      tamoxifen only (n=2)
    Died (n=2)
    Questionnaire not returned
      (n=6)
Lost to follow-up at 6 months
  (n=7):
    Questionnaire not returned
      (n=4)
    Too ill (n=1)
    Not contactable (n=2)
Lost to follow-up at 6 months
  (n=4):
    Questionnaire not returned
      (n=2)
    Died (n=1)
    Withdrew (n=1)
Not assessed at 12 weeks, but
  assessed at 6 months (n=7):
    Questionnaire not returned
      (n=6)
    Not contactable (n=1)
Not assessed at 12 weeks, but
  assessed at 6 months (n=7):
    Questionnaire not returned
      (n=6)
    Not contactable (n=1)
Fig 1 | Flow of participants through trial
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per cent of patients in the intervention group and 20%
in the control group reported at least one night in hos-
pital, and 72% and 84% reported at least one visit to
their general practitioner. The intervention group
reported fewer nights in hospital (Mann-Whitney test,
P=0.044) and fewer visits to their general practitioner
(P=0.011) than the control group.
DISCUSSION
Principal findings
Women of all ages (range 29-76 years) and types of
occupation were interested in taking part in this
study. The main reason for lack of interest was the dis-
tance needed for travel to exercise classes. After
12 weeks of supervised exercise, the intervention
group showed benefits in physical and psychological
functioning in comparison with the control group. No
adverse events were reported. The benefits to the inter-
vention group reported at 12weeksweremaintained to
the six month follow-up, with the exception of self
reported minutes of physical activity. The benefits to
breast cancer specific quality of life (FACT-B) from the
intervention emerged only at the six month follow-up,
whenmostwomenwere post-treatment. Similar results
duringbreast cancer treatment havebeen reported, but
the exercise intervention was either home based or an
individualised gym programme and no follow-up data
were reported.22
Strengths and weaknesses
This is the first full scale randomised controlled trial in
the UK of a group based exercise programme for
breast cancer patients during treatment and has the lar-
gest sample size of published exercise trials in breast
cancer. The study had an appropriate range and num-
ber of participants and is unique in including a
follow-up. The dropout rate from the trial was 14%,
which is similar to other studies on exercise in
cancer.23
Oneweakness is thatwedonot knowwhich aspect of
the group exercise experience provided most benefit.
Our qualitative data suggest that the group itself was an
important aspect and that exercise in standard settings
did not provide the same benefits.24 However, studies
that have used appropriate comparison groups to rule
Table 1 | Baseline characteristics for all participants and by intervention group. Values are numbers (percentages) unless stated
otherwise
Characteristic All participants (n=201) Exercise group (n=99) Control group (n=102)
Mean (SD) age (years) 51.6 (9.5) 51.3 (10.3) 51.8 (8.7)
Treatment plan:
Chemotherapy 15 (7.5) 8 (8.1) 7 (6.9)
Radiotherapy 57 (28.4) 28 (28.3) 29 (28.4)
Combination 129 (64.2) 63 (63.6) 66 (64.7)
Study site:
1 33 (16.4) 17 (17.2) 16 (15.7)
2 151 (75.1) 74 (74.7) 77 (75.5)
3 17 (8.5) 8 (8.1) 9 (8.8)
Mean (SD) height (cm) 160.8 (6.1) 160.6 (5.9) 161.1 (6.3)
Mean (SD) weight (kg) 70.8 (14.6) 70.2 (12.5) 71.5 (16.4)
Mean SD body mass index 27.4 (5.6) 27.3 (5.2) 27.5 (6.0)
Mean (SD) days since diagnosis 162.0 (73.8) 162.2 (78.0) 161.9 (69.8)
Mastectomy 81 (40.3) 39 (39.4) 42 (41.2)
Lumpectomy 119 (59.2) 59 (59.6) 60 (58.8)
Reconstructive surgery 23 (11.4) 13 (13.1) 10 (9.8)
Current employment status:
Full/part time 29 (14.4) 16 (16.2) 13 (12.7)
Sick 111 (55.2) 49 (49.5) 62 (60.8)
Housewife 26 (12.9) 14 (14.1) 12 (11.8)
Retired 35 (17.4) 20 (20.2) 15 (14.7)
Occupation (before diagnosis): (n=171) (n=82) (n=89)
Professional 48 (28.1) 25 (30.5) 23 (25.8)
Managerial 35 (20.5) 18 (22.0) 17 (19.1)
Clerical 55 (32.2) 26 (31.7) 29 (32.6)
Manual 33 (19.3) 13 (15.9) 20 (22.5)
WHAT IS ALREADY KNOWN ON THIS TOPIC
Exercise has a large potential to improve physical and psychosocial aspects of quality of life
in women with breast cancer during and after treatment
Most studies have involved home based or individualised gym based exercise programmes
None of the existing evidence comes from the UK or a National Health Service setting
WHAT THIS PAPER ADDS
Supervised group exercise provided functional and psychological benefits in both the short
term and long term for women having treatment for breast cancer
Clinicians should encourage physical activity for patients, and policymakers should consider
including exercise opportunities in cancer rehabilitation services
RESEARCH
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out a placebo effect suggest that these beneficial effects
cannot be completely attributed to non-specific char-
acteristics of the programme (such as increased atten-
tion from fitness instructors) or support received from
fellow patients.22 25 In addition, improvements in the
12 minute walk and shoulder mobility tests in favour
of the intervention group aremore directly attributable
to the exercise than to the group effect.
Table 2 | Outcome variables and intervention effect estimates (95%confidence intervals) with P values*
Outcome variable
Mean (SD) Effect estimates (exercise−control)
Baseline 12 weeks 6 months 12 weeks 6 months
Maximum No:
Control 102 92 95 NA NA
Exercise 99 82 82
FACT-G:
Control 73.3 (15.0) 77.3 (14.4) 77.1 (17.0) 1.0 (−2.7 to 4.7); P=0.60 3.6 (0.0 to 7.3); P=0.053
Exercise 77.0 (12.4) 81.0 (16.8) 83.2 (12.8)
FACT-GP:
Control 20.0 (5.7) 21.9 (5.1) 22.3 (5.3) 0.4 (−0.8 to 1.7); P=0.50 0.7 (−0.5 to 2.0); P=0.27
Exercise 21.4 (4.8) 23.1 (4.9) 23.9 (4.3)
FACT-GS:
Control 23.7 (4.8) 23.4 (5.0) 22.9 (5.5) 0.9 (−0.2 to 2.1); P=0.10 1.4 (0.3 to 2.5); P=0.014
Exercise 23.6 (5.1) 24.2 (4.6) 23.9 (4.8)
FACT-GE:
Control 18.3 (4.7) 18.9 (4.4) 18.6 (4.5) 0.7 (−0.3 to 1.7); P=0.19 0.6 (−0.4 to 1.7); P=0.23
Exercise 19.0 (3.7) 20.1 (4.2) 19.7 (4.0)
FACT-GF:
Control 11.3 (5.0) 13.1 (5.0) 13.6 (5.1) 0.4 (−0.8 to 1.6); P=0.49 1.1 (−0.1 to 2.3); P=0.067
Exercise 12.9 (4.7) 14.6 (4.6) 15.8 (4.2)
FACT-B subscale:
Control 21.3 (7.0) 22.4 (7.2) 24.2 (6.3) 2.5 (1.0 to 3.9); P=0.0007 1.5 (0.1 to 2.9); P=0.039
Exercise 22.2 (6.7) 25.8 (6.0) 26.1 (5.6)
FACT-F subscale:
Control 32.8 (12.7) 36.0 (12.1) 37.6 (11.8) 2.3 (−0.4 to 5.0); P=0.091 1.9 (−0.7 to 4.6); P=0.15
Exercise 36.3 (11.7) 40.3 (10.4) 41.3 (9.7)
FACT-ES subscale:
Control 39.9 (9.3) 40.3 (9.7) 39.7 (10.2) 1.1 (−1.2 to 3.4); P=0.36 1.1 (−1.2 to 3.4); P=0.35
Exercise 40.6 (9.6) 41.6 (9.1) 41.0 (9.8)
BDI score:
Control 13.0 (7.4) 11.5 (8.6) 10.8 (7.5) −1.7 (−3.7 to0.2); P=0.083 −1.8 (−3.8 to 0.1); P=0.064
Exercise 11.8 (6.9) 8.6 (6.8) 8.4 (7.2)
PANAS positive:
Control 28.0 (9.2) 29.3 (9.8) 29.2 (10.5) 4.0 (1.8 to 6.3); P=0.0005 3.9 (1.6 to 6.1); P=0.0008
Exercise 27.7 (8.4) 33.4 (8.5) 33.0 (8.1)
PANAS negative:
Control 19.1 (7.7) 17.7 (7.4) 17.4 (6.9) −0.7 (−2.5 to 1.0); P=0.41 −0.7 (−2.5 to 1.0); P=0.39
Exercise 17.3 (6.9) 15.6 (6.6) 15.7 (6.1)
12 minute walk (m):
Control 975 (235) 984 (221) 1013 (190) 129 (83 to 176); P<0.0001 105 (60 to 151); P<0.0001
Exercise 997 (211) 1135 (143) 1127 (166)
SPAQ leisure activity (minutes):
Control 365 (288) 416 (405) 427 (370) 182 (75 to 289); P=0.0009 64 (−41 to 169); P=0.23
Exercise 367 (306) 585 (385) 492 (327)
Shoulder mobility score:
Control 30.5 (5.6) 30.1 (5.9) 29.6 (6.2) 2.6 (1.6 to 3.7); P<0.0001 2.5 (1.4 to 3.6); P<0.0001
Exercise 31.1 (5.4) 33.2 (4.6) 32.8 (4.8)
Body mass index:
Control 27.5 (6.0) 27.9 (6.9) 27.0 (5.4) −0.5 (−1.3 to 0.2); P=0.16 −0.2 (−0.9 to 0.5); P=0.59
Exercise 27.3 (5.2) 26.9 (4.3) 27.0 (4.6)
BDI=Beck depression inventory; FACT=functional assessment of cancer therapy (see text for core domains and subscales); NA=not applicable;
PANAS=positive and negative affect scale; SPAQ=Scottish physical activity questionnaire.
*Based on mixed effects models with adjustment for baseline values, study site, treatment at baseline, and age.
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Meaning
Adiagnosis of cancer can signal a “teachablemoment,”
and patients often show an enhanced motivation to
change lifestyle behaviours.26 Women benefited from
the provision of exercise classes, and these benefits
may be caused by the exercise itself, by the group
experience, or by a combination of both. Clinicians
should encourage activity for patients with cancer,
and policy makers should consider including opportu-
nities for exercise in cancer rehabilitation services,
similar to the exercise component in cardiac rehabili-
tation. Further research is needed on the effects of exer-
cise on patients with and survivors of cancers other
than breast cancer. In addition, home based pro-
grammes need to be evaluated, as many women
could not attend exercise classes because of the dis-
tance they needed to travel; this would also allow a
test of exercise alone without the group effect.
Conclusion
Supervised group exercise in addition to usual care for
women receiving treatment for early stage breast can-
cer provided functional and psychological benefit at
the end of a 12 week programme and at the six
month follow-up.
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FACT-GS
FACT-GE
FACT-GF
FACT-B subscale
FACT-F subscale
FACT-ES subscale
BDI score
PANAS positive
PANAS negative
12 minute walk
SPAQ leisure
Shoulder mobility
Body mass index
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<0.0001
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<0.0001
0.59
p
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negative affect scale; SPAQ=Scottish physical activity
questionnaire
Nights in
hospital
P
a
rt
ic
ip
a
n
ts
 (
%
)
None
0
20
40
60
80
100
One or more
Visits to general
practitioner
None One or more
Control
Exercise
Fig 3 | Percentages of patients in the control and intervention
groups who reported at least one night in hospital or at least
one visit to their general practitioner during the study
RESEARCH
page 6 of 7 BMJ | ONLINE FIRST | bmj.com
6 Irwin M, McTiernan A, Bernstein L, Gilliland F, Baumgartner R,
Baumgartner K, et al. Physical activity levels among breast cancer
survivors.Med Sci Sports Exerc 2004;36:1484-91.
7 HolmesMD, ChenWY, FeskanichD, Kroenke CH, Colditz GA. Physical
activity and survival after breast cancer diagnosis. JAMA
2005;293:2479-86.
8 McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR,
Courneya KS. Effects of exercise on breast cancer patients and
survivors: a systematic review and meta-analysis. CMAJ
2006;175:34-41.
9 Markes M, Brockow T, Resch K. Exercise for women receiving
adjuvant therapy for breast cancer. Cochrane Database Syst Rev
2006;(4):CD005001.
10 Campbell A, Whyte F, Mutrie N. Strategies to improve recruitment to
an exercise intervention during breast cancer treatment. Clinical
Effectiveness in Nursing 2007;9:211-3.
11 Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The
functional assessment of cancer therapy scale: development and
validation of the general measure. J Clin Oncol 1993;11:570-9.
12 Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al.
Reliability and validity of the functional assessment of cancer
therapy—breast quality-of-life instrument. J Clin Oncol
1997;15:974-86.
13 Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of
quality of life in women undergoing hormonal therapy for breast
cancer: validation of an endocrine symptom subscale for the FACT-B.
Breast Cancer Res Treat 1999;55:187-97.
14 Beck AT, Steer RA, Brown GK.Manual for the Beck depression
inventory-2. San Antonio, Texas: Psychological Corporation, 1996.
15 Watson D, Clark L, Tellegen A. Development and validation of brief
measures of positive and negative effect: the PANAS scales. J Pers
Soc Psychol 1988;54:1063-70.
16 Lowther M, Mutrie N, Loughlan C, McFarlane C. Development of a
Scottish physical activity questionnaire: a tool for use in physical
activity interventions. Br J Sports Med 1999;33:1-6.
17 McGavin CR, Gupta SP, McHardy GJR. Twelve-minute walking test for
assessing disability in chronic bronchitis. BMJ 1976;i:822-3.
18 Halverstadt A, Leonard A. Essential exercises for breast cancer
survivors. Boston Massachusetts: Harvard Common Press, 2000.
19 Courneya KS, Mackey JR, McKenzie D. Exercise for breast cancer
survivors: research evidenceand clinical guidelines.PhysSportsmed
2002;30(8):33-42.
20 MarcusB, EatonC, Rossi JS, Harlow L. Self-efficacy, decision-making,
and stages of change: an integrative model of physical exercise. J
Appl Soc Psychol 1994;24:489-508.
21 Campbell A, Mutrie N,White F, McGuire F, Kearney N. A pilot study of
a supervised group exercise programme as a rehabilitation
treatment for women with breast cancer receiving adjuvant
treatment. Eur J Oncol Nurs 2005;9:56-63.
22 Segal R, Evans W, Johnson D, Smith J, Colletta S, Gayton J, et al.
Structured exercise improves physical functioning in women with
stages I and II breast cancer: results of a randomizedcontrolled trial. J
Clin Oncol 2001;19:657-65.
23 Oldervoll LM, Kaasa S, Hjermstad MJ, Lund JA, Loge JH. Physical
exercise results in the improved subjective well-being of a few or is
effective rehabilitation for all cancer patients? Eur J Cancer
2004;40:951-62.
24 Emslie C, Whyte F, Campbell A, Mutrie N, Lee L, Ritchie D, et al. “I
wouldn’t have been interested in just sitting round a table talking
about cancer”; exploring the experiences of women with breast
cancer in a group exercise trial. Health Educ Res (in press).
25 Courneya KS, Friedenreich C, Sela R, Quinney A, Rhodes R,
Handman M. The group psychotherapy and home-based physical
exercise (GROUP-HOPE) trial in cancer survivors: physical fitness and
quality of life outcomes. Psycho-Oncology 2003;12:357-74.
26 Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the
crest of the teachable moment: promoting long-term health after the
diagnosis of cancer. J Clin Oncol 2005;23:5814-30.
Accepted: 26 December 2006
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 7 of 7
